This topic contains a solution. Click here to go to the answer

Author Question: Research has shown that the key to survival of a cardiac arrest victim is: A) the degree of ... (Read 74 times)

bobthebuilder

  • Hero Member
  • *****
  • Posts: 567
Research has shown that the key to survival of a cardiac arrest victim is:
 
  A) the degree of training the rescuer has.
  B) early CPR and early defibrillation.
  C) the victim's will to live.
  D) proper assessment.

Question 2

The best way to determine responsiveness is to:
 
  A) take the victim's pulse at the wrist.
  B) look, listen, and feel for breathing.
  C) tap the shoulder asking loudly, Are you okay?
  D) check the victim's vital signs.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

fraziera112

  • Sr. Member
  • ****
  • Posts: 356
Answer to Question 1

Answer: B

Answer to Question 2

Answer: C




bobthebuilder

  • Member
  • Posts: 567
Reply 2 on: Jul 12, 2018
Thanks for the timely response, appreciate it


fatboyy09

  • Member
  • Posts: 358
Reply 3 on: Yesterday
Wow, this really help

 

Did you know?

Alcohol acts as a diuretic. Eight ounces of water is needed to metabolize just 1 ounce of alcohol.

Did you know?

To maintain good kidney function, you should drink at least 3 quarts of water daily. Water dilutes urine and helps prevent concentrations of salts and minerals that can lead to kidney stone formation. Chronic dehydration is a major contributor to the development of kidney stones.

Did you know?

In the United States, congenital cytomegalovirus causes one child to become disabled almost every hour. CMV is the leading preventable viral cause of development disability in newborns. These disabilities include hearing or vision loss, and cerebral palsy.

Did you know?

You should not take more than 1,000 mg of vitamin E per day. Doses above this amount increase the risk of bleeding problems that can lead to a stroke.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library